Active Stocks
Fri Jun 14 2024 15:58:47
  1. HDFC Bank share price
  2. 1,597.45 1.05%
  1. State Bank Of India share price
  2. 840.20 -0.44%
  1. Tata Steel share price
  2. 183.05 0.30%
  1. ICICI Bank share price
  2. 1,105.10 -0.20%
  1. Kotak Mahindra Bank share price
  2. 1,717.00 -0.54%
Business News/ Markets / Stock Markets/  Max Healthcare share price falls 5% in 2 days on Q4 results: Should you sell or hold?
BackBack

Max Healthcare share price falls 5% in 2 days on Q4 results: Should you sell or hold?

Max Healthcare share price that has risen by around 44% in last one year, is down more than 10% since highs in February and around 5% since Q4 results on 22 May. The Q4 results as per analysts were in line post completion of acquisitions. Buy or Sell?

Max Healthcare Institute: Brownfield additions to aid growth over next few yearsPremium
Max Healthcare Institute: Brownfield additions to aid growth over next few years

Q4 Results Review:  Max Healthcare share price has risen around 44% in last one year.

The ongoing expansions and acquisitions driving earnings outlook  is the key driver for the Max Healthcare share price. Max Healthcare added 750 beds to its capacities in Q4 through acquisitions.

However, Max Healthcare share price has been on a down trend in last two trading sessions post results and is down more than 5%. Notably at close to 790 on the NSE, the Max Healthcare share price is down more than 10% from 52-week highs seen in February.

Analyst views

Analysts remain positive on growth being fueled by expansions.  Analysts at Jefferies India Private Ltd have maintained Buy ratings on Max Healthcare post Q4. Their Q4 review report said that after In-line 4Q, there is bullish outlook for FY26. They have target price of 940 for Max Healthcare share price, which indicates around 17% upside

Analysts at Prabhudas Lilladher also said that the results were in line and growth is on track. Their target price stands at 925.

Analysts at Kotak Institutional Equities though also see strong ebitda growth to be fueled by brownfield expansions, nevertheless say that the same is factored in the share prices

Brownfield Capacities to fuel growth

Abhay Soi, Chairman and Managing Director, Max Healthcare Institute post Q4 Results said that “We have consummated two long drawn inorganic deals during the quarter. These transactions add significant capacity going forth and allow for additional brownfield opportunities in the fast growing markets" 

Also Read- Market Cap of NSE-listed companies surges to $5 trillion from $4 trillion in just 6 months

Moving forward the growth is likely to be driven by acquired capacities and Brownfield expansions, The 300 bed capacity will be added in early June. There is going to be 100 bed expansions in Lucknow by December'2024, and there after plenty of capex lined up to fuel growth including expansions at Nanavati Max Hospital ,200 beds to added in Mohali, 300 beds in Saket, New Delhi. All these brownfield expansions will fuel explosive growth over next few years said Soi. The under penetration in the healthcare market is giving immense growth opportunities as per Soi.

Max Healthcare consummated transactions for 200 bedded Alexis Hospital, Nagpur and 550 bedded Sahara Hospital, Lucknow, and the Q4 results of these hospitals have been consolidated effective Feb 9, 2024 and March 7, 2024 respectively.  

Also Read- JK Lakshmi Cement share price rises 7% post Q4 results, dividend announcement: Strong operating performance drives beat

Analysts at Jefferies India Pvt Ltd that management sounded bullish for FY26, as they expect significant brownfield capacity to come online. In Lucknow, the company hopes eventually to build a cluster of hospitals like that in Delhi. At the acquired Sahara hospital, Max will add 140 new beds by 2QFY26, 50 beds by internal reconfiguration in FY26, new tower of 350 beds by 1QFY27, and will refurbish current 250 beds by December 2024 , they added.

Analysts at Kotak Institutional Equities said that with a planned 70% plus bed addition over FY2024-27, Max is amid a hectic expansion plan. Nevertheless, given 75% of the new beds to be added over FY2024-27 estimated are either brownfield or near to Max’s existing hospitals, Kotak expects Max to deliver a healthy Ebitda CAGR (compound annual growth rate)  of 23% over FY2024-27. The Ebitda growth nevertheless is fully factored in the stock price currently as per Kotak analysts.

Also Read-Responsive Industries shares jumped over 145% in 14 months; should you invest now?

In line Q4 performance.

The completed acquisitions helped Max Healthcare gross revenue at 1,890 Crore for the March'2024 quarter marking a growth of 15% year-on-year and 6% sequentially. These  included 42 Crore from two acquired hospitals at Lucknow and Nagpur and hence on a like-to-like basis, the company highlighted that its gross revenue grew by 13%

 Earnings before interest, tax, depreciation and amortisation (Ebitda) per bed on a like-to-like basis improved by +12% YoY to 78.5 lakhs in Q4 FY24, from 70.3 lakhs in Q4 FY23 and 75.6 lakhs in Q3 FY24

Net profit stood at 311 Crore in Q4 FY24 versus 320 crore in Q4 FY23 and 338 crore in Q3 FY24. The higher taxes weighed on net profit despite good operating performance

Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before taking any investment decisions

 

 

 

 

 

 

YoY and +4% QoQ

3.6 Crore Indians visited in a single day choosing us as India's undisputed platform for General Election Results. Explore the latest updates here!

ABOUT THE AUTHOR
Ujjval Jauhari
Ujjval Jauhari is a deputy editor at Mint, with over a decade of experience in newspapers and digital news platforms. He is skilled in storytelling, reporting, analysing and writing about stocks, investment ideas, markets, corporates and more. He is based in New Delhi.
Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More Less
Published: 24 May 2024, 12:04 PM IST
Next Story footLogo
Recommended For You
GENIE RECOMMENDS

Get the best recommendations on Stocks, Mutual Funds and more based on your Risk profile!

Let’s get started